Galactans from the red seaweed Amansia multifida and their effects on inflammation, angiogenesis, coagulation and cell viability

Biomedicine and Preventive Nutrition

Volumn 2, Issue 3, 2012, Pages 154-162

  Souza, Leonardo Augusto R de ^a   Dore, Celina Maria P G ^a   Castro, Allisson J G ^a   Azevedo, Tarciana C G de ^a   Oliveira, Maria Tereza B de ^a   Moura, Maria de Fátima V ^a   Benevides, Norma M B ^b   Leite, Edda Lisboa ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Angiogenesis; Cell viability; Coagulation; Galactans; Seaweed edible

Indexed keywords

GALACTAN; HEPARIN; INTERLEUKIN 6;

AMANSIA MULTIFIDA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTICOAGULATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CLOTTING; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; HEMOLYSIS; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PERITONITIS; PRIORITY JOURNAL; SEAWEED; TUMOR CELL LINE;

AMANSIA MULTIFIDA; ANIMALIA;

EID: 84866179904     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2012.03.007     Document Type: Article

References (48)

1. Talarico L.B., Zibetti G.M.R., Faria C.S.P., Scolaro A.L., Duarte E.R.M., Noseda D.M., et al. Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata. Int J Biol Macromol 2004, 34:63-71.
2. Azevedo T.C.G., Bezerra M.E., Santos M.D., Souza L.A., Marques C.T., Benevides N.M., et al. Heparinoids algal and their anticoagulant, hemorrhagic activities and platelet aggregation. Biomed Pharmacother 2009, 63:477-483.
3. Fabris F., Luzzatto G., Stefani P.M., Girolami B., Cella G., Girolami A. Heparin-induced thrombocytopenia. Haematologic 2000, 85:72-81.
4. Rocha H.A.O., Farias E.H.C., Bezerra L.C.L.M., Albuquerque I.R.L., Medeiros V.P., Queiroz K.C.S., et al. Polissacarídeos sulfatados de algas marinhas com atividade anticoagulante. Infarma-Pharmacia Brasileira 2004, 16:82-87.
5. Nader H.B., Lopes C.C., Rocha H.A., Santos E.A., Dietrich C.P. Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities. Curr Pharmacol 2004, 10:951-966.
6. Morris Christopher J. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol 2003, 225:115-121.
7. Silva F.R.F., Dore C.M.P.G., Marques C.T., Nascimento M.S., Benevides N.M.B., Rocha H.A.O., et al. Anticoagulant activity, paw edema and pleurisy induced carrageenan: action of major types of commercial carrageenans. Carbohydr Polymers 2010, 79:26-33.
8. Henriques M.G., Silva P.M., Martins M.A., Flores C.A., Cunha F.Q., Assreuy-Filho J., et al. Mouse paw edema. A new model for inflammation?. Braz J Med Res 1987, 20:243-249.
9. Salvemini D., Wang Z.Q., Wyatt P.S., Bourdon D.M., Marino M.H., Manning P.T., et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Braz J Pharmacol 1996, 118:829-838.
10. Cuzzocrea S., Zingarelli B., Gilard E., Hake P., Salzman A.L., Szabò C. Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Rad Biol Med 1998, 24:450-459.
11. Campo V.L., Kawano D.F., Silva J.D.B., Carvalho I. Carrageenans: Biological properties, chemical modifications and structural analysis - A review. Carbohydr Polymers 2009, 77:167-180.
12. Imeson A.P. Carrageenan. Handbook of hydrocolloids (p. 87-102) 2000, Woodhead Publishing Limited, Cambridge, UK. G.O. Phillips, P.A. Williams (Eds.).
13. Silva T.M.A., Alves L.G., Queiroz K.C.S., Santos M.G.L., Marques C.T., Chavante S.F., et al. Partial characterization and anticoagulant activity of a heterofucan from the brown seaweed Padina gymnospora. Braz J Med Biol Res 2005, 38:523-533.
14. Belokoneva O.S., Villegas E., Corzo G., Dai L., Nakajima T. The hemolytic activity of six arachnid cationic peptides is affected by the phosphatidylcholineto- sphingomyelin ratio in lipid bilayers. Biochimica Biophysica Acta 2003, 1617:22-30.
15. Adachi Y., Ohno N., Ohsawa K., Oikawa S., Yadomae T. Chance of biological activities of (1→3)-β-D-glucan from Grifola frondosa upon molecular weight reduction by heat treatment. Chem Pharm Bull 1990, 38:477-481.
16. Burgermeister J., Paper D.H., Vogl H., Linhardt R.J., Franz G. LaPSvS1, a (1→3)-β-galactan sulfate and its effect on angiogenesis in vivo and in vitro. Carbohydr Res 2002, 337:1459-1466.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
18. Van de valde F., Pereira L., Rollema H.S. The revised NMR chemical shift data of carrageenans. Carbohydr Res 2004, 339:2309-2313.
19. Duarte M.E., Noseda D.G., Noseda M.D., Tulio S., Pujol C.A., Damonte E.B. Inhibitory effect of sulfated galactans from the marine alga Bostrychia montagnei on herpes simplex virus replication in vitro. Phytomedicine 2001, 8:53-58.
20. Kolender A.A., Matulewicz M.C. Sulfated polysaccharides from the red seaweed Georgiella confluens. Carbohydr Res 2002, 337:57-68.
21. Mazumder S., Ghosal P.K., Pujol C.A., Carlucci M.J., Damonte E.B., Ray B. Isolation, chemical investigation and antiviral activity of polysaccharides from Gracilaria corticata (Gracilariaceae, Rhodophyta). Int J Biol Macromolecules 2002, 31:87-95.
22. Zibetti R.G.M., Duarte M.E.R., Noseda M.D., Colodi F.G., Ducatti D.R.B., Ferreira L.G., et al. Galactans from Cryptonemia species. Part II: studies on the system of galactans of Cryptonemia seminervis (Halymeniales) and on the structure of major fractions. Carbohydr Res 2004, 344:2364-2374. [2009].
23. Pereira L. Identification of phycocolloids by vibrational spectroscopy. World seaweed resources - an authoritative reference system. 2006, ETI Information Services Ltd. A.T. Critchley, M. Ohno, D.B. Larg (Eds.).
24. Pereira M.S., Mulloy B., Mourão P.A.S.J. Biol Chem 1999, 274:7656-7667.
25. Carlucci M.J., Pujol C.A., Ciancia M., Noseda M.D., Matulewicz M.C., Damonte E.B., et al. Int J Biol Macromolecules 1997, 20:97-105.
26. Mourão P.A.S., Pereira M.S., Pavão M.S.G., Mulloy B., Tollefsen D.M., Mowinckel M.C., et al. J Biol Chem 1996, 271:23973-23984.
27. Pereira M.S., Vilela-Silva A.C.E.S., Valente A.P., Mourão P.A.S. A 2-sulfated, 3-linked alpha-L-galactan is an anticoagulant polysaccharide. Carbohydr Res 2002, 337:2231-2238.
28. Alban S., Jeske W., Welzel D., Franz G., Farred J. Anticoagulant and antithrombotic actions of a semi-synthetic β-1,3 glucan sulfate. Thromb Res 1995, 78:210-220.
29. Shanmugan M., Mody K.H. Heparinoid-active sulphated polysaccharides from marine algae as potential blood anticoagulant agents. Curr Sci 2000, 79:1672-1683.
30. Levi M. Cell surface-targeted in systemic infection and inflammation. Blood 2004, 104:1231-1232.
31. Dutra R.C., Tavares C.Z., Ferraz S.O., Sousa O.V., Pimenta D.S. Investigation of analgesic and anti-inflammatory activities of Echinodorus grandiflorus rhizomes methanol extract. Braz J Pharmacognosy 2006, 16:469-474.
32. Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1967, 111:544-547.
33. Ferreira S.H., Lorenzetti B.B., Poole S. Bradykinin initiates cytokine mediated inflammatory hyperalgesia. Br J Pharmacol 1993, 110:1227-1231.
34. Nishimoto N., Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004, 4:386-391.
35. Barton B.E. IL-6: insights into novel biological activities. Clin Immunol Immunopathol 1997, 85:16-20.
36. Frode T.S., Souza G.E.P., Calixto J.B. The effects of IL-6 and IL -10 and their specific antibodies in the acute inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine 2002, 17:149-156.
37. Ochi K., Watanabe Y., Okui K., Shindo M. Crystalline salts of sucrose octasulfate. Chem Pharm Bull 1980, 28:638-641.
38. Paper D.H., Vogl H., Franz G. Relevance of tumor models for anticancer drug development, contributions to oncology. Low molecular weight galactan sulfates as angiogenesis inhibitors 1999, 54:191-199. Karger-Verlag, Basel.
39. Paper D.H., Vogl H., Franz G., Hoffman R. Natural products as angiogenesis inhibitors. Macromol Symp 1995, 99:219-225.
40. Käsbauer C.W., Paper D.H., Franz G. Sulfated β-(1→4)-galacto-oligosaccharides and their effect on angiogenesis. Carbohydr Res 2001, 330:427-430.
41. Abraham R., Fabian R.J., Goldberg L., Coulston F. Role of lysosomes in carrageenan-induced cecal ulceration. Gastroenterology 1974, 67:1169-1181.
42. Watt J., Marcus R. Experimental ulcerative disease of the colon in animals. Gut 1973, 14:506-510.
43. Benitz K.F., Goldberg L., Coulston F. Intestinal effects of carrageenans in the rhesus monkey (Macaca muiatta). Food Cosmet Toxicol. 1973, 11:565-575.
44. Bhattacharyya S., Borthakur A., Dudeja P.K., Tobacman J.K. Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro. J Nutr 2008, 138:469-475.
45. Joint FAO/WHO Expert Committee on Food Additives (2001). Compendium of Food Additives Specifications, Addendum 9: FAO food and nutrition paper no. 52 (pp. 192-194) Rome: FAO.
46. Joint FAO/WHO Expert Committee on Food Additives (2007). JECFA Sixty-eighth Meeting: summary and conclusions. Geneva, June 19-28, 2007.
47. Zhou G., Sun Y., Xin H., Zhang Y., Xu Z., Li Z. In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacol Res 2004, 50:47-53.
48. Ishizaka S., Hasuma T., Otani S., Morisawa S. Lymphocyte activation by purified carrageenan. J Immunol 1980, 125:2232-2235.